MedTrace Logo

Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance

NCT02776098 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2024-03-07

No results posted yet for this study

Summary

This study will investigate the link between glucose abnormalities and elements critical to muscle function including mass, composition and energy metabolism. the primary goal of the study is to determine whether Cystic Fibrosis (CF) disease is associated with muscle dysfunction, especially in the presence of glucose intolerance. This is a longitudinal cohort study of 3 main groups: CF subjects without Cystic Fibrosis-related diabetes (CFRD), healthy matched controls and CF subjects with newly diagnosed CFRD started on insulin therapy.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Clement L Ren, MD · Children's Hospital of Philadelphia

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2024-03-04
Completion
2024-03-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02776098 on ClinicalTrials.gov